Bixiye
Isturisa® (osilodrostat) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 1921 - 1930 ee natiijooyinka 3688
Bixiye
Growth Hormone - Medicaid
Oggolaanshaha Hore
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP1-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 15, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
QP2-22 MHCP Pharmacy Benefit Exclusion for Nexviazyme™
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
QP3-22 Commercial Pharmacy Benefit Exclusion for Loreev XR and Sertraline Capsules
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
Myalept® (metreleptin) - Commercial - Effective Date 02/01/2025
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Bixiye
QP4-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
QP5-22 New Access Point for Prior Authorization Look Up Tool and Blue Cross Website Updates
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
QP6-22 New Telehealth Place of Service Code 10
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
P1-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 03, 2022